Expression of toll‐like receptors in recurrent pleomorphic adenoma and carcinoma ex pleomorphic adenoma
APMIS · 2025
DOI: 10.1111/apm.13505 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Maria K Jauhiainen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Adenoma, Pleomorphic, Salivary Gland Neoplasms, Toll-Like Receptors. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Funding for the Helsinki University Hospital, HusLab, Doctoral Programme in Clinical Research University of Helsinki.
Abstract (Originalsprache)
Pleomorphic adenoma (PA) is a benign salivary gland tumour that may recur or undergo malignant transformation (CXPA). Toll‐like receptors (TLR) mediate immune responses triggered by various agents such as viruses and are related to tumour formation either by stimulating or suppressing their growth, with variation across different tumour entities. We compared TLR immunohistochemical expression in PA, its recurrent counterparts and CXPA and evaluated the effect of virus presence in these tumours. We studied the expression of TLR‐2, ‐3, ‐5, ‐7 and ‐9 in 25 PA, 34 recurrent PA and 15 CXPA tumour samples. In addition, we examined the TLR expression levels in the presence and absence of herpes‐, polyoma‐ and parvovirus DNA in a subset of tumours (n = 20). CXPA expressed significantly more TLR‐5 and TLR‐9 in the nucleus, cytoplasm and cell membrane compared with benign PA. The presence of virus DNA did not notably affect the TLR expression. TLR expression patterns seem to reflect tumour behaviour but are independent of the presence of viruses tested in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Virology, University of Helsinki, Helsinki, Finland.
- Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of Pathology, University Hospital of Helsinki and Turku, Helsinki, Finland.
- Translational Cancer Medicine, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
ORCID-Profile: Maria K Jauhiainen, Anttoni Markkanen, Timo Atula, Katri Aro, Caj Haglund, Maria Söderlund-Venermo, Antti A Mäkitie, Saku T Sinkkonen, Jaana Hagström
Förderung
- State Funding for the Helsinki University Hospital
- HusLab
- Doctoral Programme in Clinical Research University of Helsinki
Zitieren
APA
Jauhiainen, M. K., Markkanen, A., Atula, T., Aro, K., Haglund, C., Söderlund-Venermo, M., Mäkitie, A. A., Sinkkonen, S. T., & Hagström, J. (2025). Expression of toll‐like receptors in recurrent pleomorphic adenoma and carcinoma ex pleomorphic adenoma. APMIS. https://doi.org/10.1111/apm.13505
Vancouver
Jauhiainen MK, Markkanen A, Atula T, Aro K, Haglund C, Söderlund-Venermo M, et al. Expression of toll‐like receptors in recurrent pleomorphic adenoma and carcinoma ex pleomorphic adenoma. APMIS. 2025. doi:10.1111/apm.13505
BibTeX
@article{Jauhiainen2025,
author = {Jauhiainen, Maria K and Markkanen, Anttoni and Atula, Timo and Aro, Katri and Haglund, Caj and Söderlund-Venermo, Maria and Mäkitie, Antti A and Sinkkonen, Saku T and Hagström, Jaana},
title = {Expression of toll‐like receptors in recurrent pleomorphic adenoma and carcinoma ex pleomorphic adenoma},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.13505}
}
EUVIMED